These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17587823)

  • 1. Posttranslational truncation of E-cadherin and significance for tumour progression.
    Masterson J; O'Dea S
    Cells Tissues Organs; 2007; 185(1-3):175-9. PubMed ID: 17587823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.
    Rashid MG; Sanda MG; Vallorosi CJ; Rios-Doria J; Rubin MA; Day ML
    Cancer Res; 2001 Jan; 61(2):489-92. PubMed ID: 11212238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadherins in development and cancer.
    Stemmler MP
    Mol Biosyst; 2008 Aug; 4(8):835-50. PubMed ID: 18633485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A causal role for E-cadherin in the transition from adenoma to carcinoma.
    Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G
    Nature; 1998 Mar; 392(6672):190-3. PubMed ID: 9515965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor progression: Small GTPases and loss of cell-cell adhesion.
    Lozano E; Betson M; Braga VM
    Bioessays; 2003 May; 25(5):452-63. PubMed ID: 12717816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer.
    Imamichi Y; König A; Gress T; Menke A
    Oncogene; 2007 Apr; 26(16):2381-5. PubMed ID: 17043655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
    Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
    Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas.
    Birchmeier W; Weidner KM; Hülsken J; Behrens J
    Semin Cancer Biol; 1993 Aug; 4(4):231-9. PubMed ID: 8400145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin, estrogens and cancer: is there a connection?
    Blaschuk OW; Munro SB; Farookhi R
    Can J Oncol; 1994 Nov; 4(4):291-301. PubMed ID: 10874487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many new down- and up-regulatory signaling pathways, from known cancer progression suppressors to matrix metalloproteinases, differ widely in cells of various cancers.
    Delassus GS; Cho H; Hoang S; Eliceiri GL
    J Cell Physiol; 2010 Aug; 224(2):549-58. PubMed ID: 20432456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of the survival/apoptosis balance by E-cadherin: role in enterocyte anoikis].
    Fouquet S; Lugo-Martínez VH; Chambaz J; Cardot P; Pinçon-Raymond M; Thenet S
    J Soc Biol; 2004; 198(4):379-83. PubMed ID: 15969344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin mutations and cell motility: a genotype-phenotype correlation.
    Mateus AR; Simões-Correia J; Figueiredo J; Heindl S; Alves CC; Suriano G; Luber B; Seruca R
    Exp Cell Res; 2009 May; 315(8):1393-402. PubMed ID: 19268661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
    Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
    Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysialylated NCAM represses E-cadherin-mediated cell-cell adhesion in pancreatic tumor cells.
    Schreiber SC; Giehl K; Kastilan C; Hasel C; Mühlenhoff M; Adler G; Wedlich D; Menke A
    Gastroenterology; 2008 May; 134(5):1555-66. PubMed ID: 18384787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building the synovium: cadherin-11 mediates fibroblast-like synoviocyte cell-to-cell adhesion.
    Kiener HP; Brenner MB
    Arthritis Res Ther; 2005; 7(2):49-54. PubMed ID: 15743489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanism of cancer seeding: adhesion molecules and signal transduction networks].
    Mareel M; Vermeulen S; Bracke M
    Verh K Acad Geneeskd Belg; 1997; 59(4):327-51. PubMed ID: 9490922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage.
    Fuchs M; Hermannstädter C; Hutzler P; Häcker G; Haller F; Höfler H; Luber B
    Exp Cell Res; 2008 Jan; 314(1):153-63. PubMed ID: 17959171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
    Deplazes J; Fuchs M; Rauser S; Genth H; Lengyel E; Busch R; Luber B
    Hum Mol Genet; 2009 Oct; 18(19):3632-44. PubMed ID: 19584084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial E- and P-cadherins: role and clinical significance in cancer.
    Paredes J; Figueiredo J; Albergaria A; Oliveira P; Carvalho J; Ribeiro AS; Caldeira J; Costa AM; Simões-Correia J; Oliveira MJ; Pinheiro H; Pinho SS; Mateus R; Reis CA; Leite M; Fernandes MS; Schmitt F; Carneiro F; Figueiredo C; Oliveira C; Seruca R
    Biochim Biophys Acta; 2012 Dec; 1826(2):297-311. PubMed ID: 22613680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.